Nathan Robertson serves as the Director at LabGenius, where he leverages his extensive expertise in biochemistry, biophysics, and molecular biology to drive innovative projects in antibody discovery. With a robust background as a Principal Scientist, Nathan has honed his skills in membrane proteins, protein chemistry,...
Nathan Robertson serves as the Director at LabGenius, where he leverages his extensive expertise in biochemistry, biophysics, and molecular biology to drive innovative projects in antibody discovery. With a robust background as a Principal Scientist, Nathan has honed his skills in membrane proteins, protein chemistry, and structural biology techniques, making him a pivotal figure in the development of next-generation therapeutics. His leadership at LabGenius is characterized by a commitment to integrating synthetic biology, robotic automation, and machine learning, which are essential in accelerating the discovery and optimization of high-performing immunotherapies.
At LabGenius, Nathan is currently spearheading key projects focused on the development of a wholly-owned pipeline of immunotherapies aimed at treating solid tumors. His team's recent research breakthroughs underscore their capability to discover novel antibodies with enhanced specificity and efficacy, a testament to the innovative methodologies employed under his direction. Nathan’s proficiency in bioinformatics and assay development plays a crucial role in streamlining the drug design process, ensuring that the therapeutic candidates not only meet but exceed industry standards.
With a PhD from Imperial College London, Nathan's academic foundation complements his hands-on experience in cell culture, purification, and X-ray crystallography, enabling him to navigate complex scientific challenges with ease. His vision for LabGenius extends beyond immediate project goals; he is dedicated to fostering a culture of collaboration and continuous learning, ensuring that the company remains at the forefront of the biopharmaceutical landscape. Through his leadership, LabGenius is poised to make significant strides in the fight against cancer, ultimately transforming the therapeutic landscape for patients worldwide.
